Literature DB >> 35035697

RNF128 suppresses the malignancy of colorectal cancer cells via inhibition of Wnt/β-catenin signaling.

Yue Zhu1,2, Yujie Gan1, Renrui Zou1, Huanhuan Sha1, Ya Lu1, Yuan Zhang1, Jifeng Feng1.   

Abstract

PURPOSE: Colorectal cancer (CRC) is one of the most frequent tumors and causes of mortality worldwide. Ubiquitin ligase was reported to regulate multiple cellular processes, including tumorigenesis. As ubiquitin E3 ligases, RING-finger proteins play a key role in physiological and pathophysiological processes.
METHODS: We compared the expression levels of RNF128 in CRC tissues by western-blotting and qRT-PCR. Knockdown and overexpression of RNF128 were performed to examine its effect on proliferation and metastasis of CRC cells. Using western blot and co-immunoprecipitation assays, we explored the possible mechanisms underlying the effect of RNF128 in CRC cells.
RESULTS: We found that the expression level of RNF128 was correlated with the CRC tumorigenicity. Overexpression or knockdown of RNF128 suppressed or elevated CRC cell proliferation, migration and invasion, respectively. We further determined that RNF128 regulated β-catenin ubiquitination and thus inhibited Wnt/β-catenin signaling in CRC cells.
CONCLUSION: Our research demonstrated that RNF128 inhibited cell proliferation and metastasis of CRC cells via Wnt/β-catenin signaling-mediated deubiquitination. AJTR
Copyright © 2021.

Entities:  

Keywords:  RNF128; Wnt/β-catenin signaling; colorectal cancer; ubiquitination

Year:  2021        PMID: 35035697      PMCID: PMC8748172     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  36 in total

1.  Reversible regulation of SATB1 ubiquitination by USP47 and SMURF2 mediates colon cancer cell proliferation and tumor progression.

Authors:  Le Yu; Ling Dong; Yang Wang; Liu Liu; Hua Long; Hui Li; Jinping Li; Xiaolong Yang; Zhaojian Liu; Guangjie Duan; Xiaotian Dai; Zhenghong Lin
Journal:  Cancer Lett       Date:  2019-02-08       Impact factor: 8.679

Review 2.  Ubiquitin Ligases: Structure, Function, and Regulation.

Authors:  Ning Zheng; Nitzan Shabek
Journal:  Annu Rev Biochem       Date:  2017-03-27       Impact factor: 23.643

3.  Grail as a molecular determinant for the functions of the tumor suppressor p53 in tumorigenesis.

Authors:  Y-C Chen; J Y-H Chan; Y-L Chiu; S-T Liu; G Lozano; S-L Wang; C-L Ho; S-M Huang
Journal:  Cell Death Differ       Date:  2013-02-01       Impact factor: 15.828

4.  Ectodysplasin A receptor (EDAR) promotes colorectal cancer cell proliferation via regulation of the Wnt/β-catenin signaling pathway.

Authors:  Bin Wang; Yanfang Liang; Xingxing Chai; Shasha Chen; Ziyu Ye; Ronggang Li; Xiaoping Li; Gang Kong; Yanyun Li; Xueying Zhang; Zhengping Che; Yongke You; Shicai Ye; Lili Li; Bihua Lin; Juan Huang; Mingyuan Huang; Xin Zhang; Xianxiu Qiu; Jincheng Zeng
Journal:  Exp Cell Res       Date:  2020-07-17       Impact factor: 3.905

Review 5.  Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer's disease.

Authors:  Liang Hong; Han-Chang Huang; Zhao-Feng Jiang
Journal:  Neurol Res       Date:  2014-03       Impact factor: 2.448

Review 6.  Ubiquitin ligases in oncogenic transformation and cancer therapy.

Authors:  Daniela Senft; Jianfei Qi; Ze'ev A Ronai
Journal:  Nat Rev Cancer       Date:  2017-12-15       Impact factor: 60.716

Review 7.  Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment.

Authors:  Valery Vilchez; Lilia Turcios; Francesc Marti; Roberto Gedaly
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

Review 8.  Regulation of cellular responses by deubiquitinating enzymes: an update.

Authors:  James F Burrows; James A Johnston
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

9.  Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder.

Authors:  Yi-Ying Lee; Chieh-Tien Wang; Steven Kuan-Hua Huang; Wen-Jeng Wu; Chun-Nung Huang; Ching-Chia Li; Ti-Chun Chan; Peir-In Liang; Chung-Hsi Hsing; Chien-Feng Li
Journal:  J Cancer       Date:  2016-10-25       Impact factor: 4.207

10.  Absence of Grail promotes CD8+ T cell anti-tumour activity.

Authors:  Cara Haymaker; Yi Yang; Junmei Wang; Qiang Zou; Anupama Sahoo; Andrei Alekseev; Divyendu Singh; Krit Ritthipichai; Yared Hailemichael; Oanh N Hoang; Hong Qin; Kimberly S Schluns; Tiejun Wang; Willem W Overwijk; Shao-Cong Sun; Chantale Bernatchez; Larry W Kwak; Sattva S Neelapu; Roza Nurieva
Journal:  Nat Commun       Date:  2017-08-10       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.